Dr. Choyke Discusses Screening in Prostate Cancer

Peter Choyke, MD, FACR
Published: Tuesday, Aug 15, 2017



Peter Choyke, MD, FACR, chief of the Molecular Imaging Program, National Cancer Institute, discusses screening in prostate cancer.

Conducting random biopsies do not make any sense in a modern world, says Choyke. The best strategy to identify high-grade cancer is MRI, he adds.

In terms of when to operate or radiate, practitioners find that the answer is not perfect—there is a learning curve. A lot of this has to do with good communication between the urologist and radiologist, says Choyke.
 


Peter Choyke, MD, FACR, chief of the Molecular Imaging Program, National Cancer Institute, discusses screening in prostate cancer.

Conducting random biopsies do not make any sense in a modern world, says Choyke. The best strategy to identify high-grade cancer is MRI, he adds.

In terms of when to operate or radiate, practitioners find that the answer is not perfect—there is a learning curve. A lot of this has to do with good communication between the urologist and radiologist, says Choyke.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual International Congress of Oncology Pathology™: Towards Harmonization of Pathology and Oncology StandardsAug 30, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x